Switzerland· 58609002
Prismasol 4 mmol/l Potassium, Hämofiltrations- und Hämodialyselösung
A hemofiltrates product, registered in Switzerland by Vantive GmbH and dispensed under Swissmedic category B. The same ATC class is registered in 11 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Prismasol is registered in 11 of 19 countries.
Countries holding a registration under ATC B05ZB (hemofiltrates), each read from that country’s own register.
- This record: Switzerland
- 7 of them publish a price we can compare per daily dose
Prismasol · ATC B05ZB
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
- Manufacturer
- Vantive GmbH
- Country
- Switzerland (CH)
- ATC code
- B05ZB
- ATC class
- Hemofiltrates
- Swissmedic category
- B
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B05ZB
Hemofiltrates, as other registers publish it.
- BelgiumAccusol 35Nikkiso Belgium
- BelgiumAccusol 35 Kalium 2 mmol/lNikkiso Belgium
- BelgiumAccusol 35 Kalium 4 mmol/lNikkiso Belgium
- IrelandAccusol 35 Potassium 2 mmol/lSolution for haemofiltration, haemodialysis and haemodiafiltrationNikkiso Belgium bvba
- IrelandAccusol 35 Potassium 4 mmol/lSolution for haemofiltration, haemodialysis and haemodiafiltrationNikkiso Belgium bvba
- IrelandAccusol 35 Solution for haemofiltration, haemodialysis and haemodiafiltrationNikkiso Belgium bvba
- FinlandBicaflac BufferB. Braun Avitum AG
- FinlandBicaflac Cum KaliumB. Braun Avitum AG
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e6bdd3c0-cf38-4259-b302-0076e2ea9313 GET /v1/drugs/e6bdd3c0-cf38-4259-b302-0076e2ea9313?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about Prismasol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.